A highly accomplished Director of Statistical Programming with over 22 years of industry experience with industry experience in the analysis of clinical trial data (Phase I, II, III and IV) across multiple therapeutic areas (Oncology, Gene Therapy, Neurology, Pulmonary Diseases, and Respiratory Diseases). Proven track record of successfully leading and managing statistical programming teams, timely delivery of high-quality results in fast-paced and dynamic environments. Strong analytical skills, proficient in SAS, and adept at collaborating with cross-functional teams. Expertise in industry data standards, including CDISC, SDTM, and ADaM. In-depth understanding of regulatory requirements, and Good Clinical Practice (GCP), ICH guidelines and, 21 CFR Part 11 requirements. Proven ability to manage CRO relationships and oversee programmed deliverables. A proven track record of overseeing vendors. Extensive experience supporting and leading NDA/BLA and MAA submissions. Ability to work within cross-functional global teams and possess effective communication skills, interpersonal skills, and organizational abilities. Strategic-thinking individual experienced in turning low-performing organizations into top revenue producers. Offering engaging and pleasant personality with expertise improving customer relationships.